Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide
PHASE1
To investigate the effect of three single oral doses of BIA 9-1067 (25 mg, ...
Status
Completed
Location
BIAL - Portela & Cª - Human Pharmacology Unit (UFH)
Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide
PHASE1
To investigate the effect of three single oral doses of BIA 9-1067 (25 mg, ...
An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites
PHASE1
The purpose of this study is to determine the rate and routes of excretion ...